Does C‐reactive protein predict the long‐term progression of interstitial lung disease and survival in patients with early systemic sclerosis?
X Liu, MD Mayes, C Pedroza, HT Draeger… - Arthritis care & …, 2013 - Wiley Online Library
Objective There are no identified clinical markers that reliably predict long‐term progression
of interstitial lung disease (ILD) in systemic sclerosis (SSc; scleroderma). Elevated C‐…
of interstitial lung disease (ILD) in systemic sclerosis (SSc; scleroderma). Elevated C‐…
Correlation of interferon‐inducible chemokine plasma levels with disease severity in systemic sclerosis
…, JD Reveille, BE Harper, HT Draeger… - Arthritis & …, 2013 - Wiley Online Library
Objective To measure interferon (IFN)–inducible chemokines in the plasma of patients with
systemic sclerosis (SSc) and investigate whether the chemokine levels are correlated with …
systemic sclerosis (SSc) and investigate whether the chemokine levels are correlated with …
HLA–DRB1* 0407 and* 1304 are risk factors for scleroderma renal crisis
…, JD Reveille, EB Gonzalez, HT Draeger… - Arthritis & …, 2011 - Wiley Online Library
Objective To examine the predictive role of HLA genetic markers in scleroderma renal crisis
(SRC), beyond the known clinical correlates, in a large population of patients with systemic …
(SRC), beyond the known clinical correlates, in a large population of patients with systemic …
[HTML][HTML] Right bundle branch block: a predictor of mortality in early systemic sclerosis
Objective To evaluate the prognostic significance of baseline electrocardiogram (ECG)
abnormalities in a multiethnic cohort of patients with early systemic sclerosis (SSc) and to …
abnormalities in a multiethnic cohort of patients with early systemic sclerosis (SSc) and to …
Can serum surfactant protein D or CC-chemokine ligand 18 predict outcome of interstitial lung disease in patients with early systemic sclerosis?
…, EB Gonzalez, DE Lewis, HT Draeger… - The Journal of …, 2013 - jrheum.org
Objective. To examine the predictive significance of 2 pneumoproteins, surfactant protein D (SP-D)
and CC-chemokine ligand 18 (CCL18), for the course of systemic sclerosis (SSc)-…
and CC-chemokine ligand 18 (CCL18), for the course of systemic sclerosis (SSc)-…
A randomised controlled trial of the reciprocating syringe in arthrocentesis
HT Draeger, JM Twining, CR Johnson… - Annals of the …, 2006 - ard.bmj.com
Objective: To evaluate the outcomes of arthrocentesis with the new highly controllable, one
handed reciprocating procedure syringe compared with a conventional syringe. Methods: …
handed reciprocating procedure syringe compared with a conventional syringe. Methods: …
Physician control of needle and syringe during aspiration-injection procedures with the new reciprocating syringe.
…, RR Sibbitt, AA Michael, DI Fu, HT Draeger… - The Journal of …, 2006 - jrheum.org
OBJECTIVE: To evaluate physician control of needle and syringe during aspiration-injection
syringe procedures by comparing the new reciprocating procedure syringe to a traditional …
syringe procedures by comparing the new reciprocating procedure syringe to a traditional …
Patients with needle phobia? Try stress-reducing medical devices: a randomized controlled trial comparing decorated and plain syringes and butterfly needles.
…, LG Kettwich, CJ Palmer, HT Draeger… - Journal of family …, 2006 - go.gale.com
Needle phobia--fear of needles, syringes, intravenous therapy, and medical devices--can
seriously compromise medical care.(1-7) We hypothesized that a novel cognitive therapy …
seriously compromise medical care.(1-7) We hypothesized that a novel cognitive therapy …
Reduced pain of intraarticular hyaluronate injection with the reciprocating procedure device
SE Nunez, HT Draeger, DP Rivero… - JCR: Journal of …, 2007 - journals.lww.com
Background: Greater than 50% of patients report significant pain with intraarticular injection
of hyaluronate. The reciprocating procedure device (RPD), also known the reciprocating …
of hyaluronate. The reciprocating procedure device (RPD), also known the reciprocating …
Measuring illness behavior in patients with systemic sclerosis
…, R Sharif, BE Harper, HT Draeger… - Arthritis care & …, 2013 - Wiley Online Library
Objective Illness behaviors (cognitive, affective, and behavioral reactions) among individuals
with systemic sclerosis (SSc; scleroderma) are of clinical concern due to relationships …
with systemic sclerosis (SSc; scleroderma) are of clinical concern due to relationships …